which is an inhaled inhibitor of galectin-3. Since then the US drugmaker has bolstered its early-stage research in fibrosis via academic partnerships with the California Institute for Biomedical ...
Galectin Therapeutics is dedicated to developing ... the most advanced form of MASH-related fibrosis. Liver cirrhosis is one of the most pressing medical needs and a significant drug development ...
Geneos Wealth Management Inc. raised its stake in Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) by 10.2% in the 4th ...
Galectin Therapeutics is dedicated to developing novel therapies ... the most advanced form of MASH-related fibrosis. Liver cirrhosis is one of the most pressing medical needs and a significant drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback